709608-85-5 Usage
Uses
Used in Pharmaceutical Synthesis:
4-Hydroxymethyl-1H-indazole serves as a crucial building block in the synthesis of pharmaceuticals and bioactive compounds. Its unique structure allows for the development of new drugs with potential therapeutic benefits.
Used in Therapeutic Applications:
4-Hydroxymethyl-1H-indazole is explored as a therapeutic agent for the treatment of various diseases and conditions, including cancer and neurological disorders. Its potential in these areas is attributed to its ability to interact with biological targets and modulate cellular processes.
Used in Antimicrobial and Antifungal Applications:
4-Hydroxymethyl-1H-indazole has been investigated for its antimicrobial and antifungal properties, making it a candidate for use in the development of new antimicrobial and antifungal agents to combat resistant strains and infections.
Used in Scientific and Industrial Research:
As a versatile and significant chemical, 4-Hydroxymethyl-1H-indazole continues to be a subject of research and development in various scientific and industrial fields, driving innovation and advancements in medicine and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 709608-85-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,9,6,0 and 8 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 709608-85:
(8*7)+(7*0)+(6*9)+(5*6)+(4*0)+(3*8)+(2*8)+(1*5)=185
185 % 10 = 5
So 709608-85-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O/c11-5-6-2-1-3-8-7(6)4-9-10-8/h1-4,11H,5H2,(H,9,10)
709608-85-5Relevant academic research and scientific papers
SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE
-
Page/Page column 126-127, (2010/11/27)
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted dihydropyridines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of C5a receptors.
